PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 194 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $303,318 | +7.4% | 9,866 | +40.5% | 0.00% | – |
| Q2 2023 | $282,510 | -52.9% | 7,020 | -52.4% | 0.00% | -100.0% |
| Q1 2023 | $599,207 | +63.5% | 14,749 | +55.4% | 0.00% | – |
| Q4 2022 | $366,433 | -15.6% | 9,489 | +18.4% | 0.00% | -100.0% |
| Q3 2022 | $434,000 | +50.2% | 8,015 | +62.2% | 0.00% | – |
| Q2 2022 | $289,000 | -60.4% | 4,941 | -48.3% | 0.00% | -100.0% |
| Q1 2022 | $730,000 | -39.2% | 9,566 | -52.8% | 0.00% | -50.0% |
| Q4 2020 | $1,200,000 | +19.2% | 20,260 | +21.6% | 0.00% | 0.0% |
| Q3 2020 | $1,007,000 | +388.8% | 16,662 | +171.5% | 0.00% | – |
| Q1 2020 | $206,000 | -84.5% | 6,137 | -82.4% | 0.00% | -100.0% |
| Q3 2019 | $1,328,000 | -48.4% | 34,872 | -33.5% | 0.00% | -50.0% |
| Q3 2018 | $2,574,000 | +977.0% | 52,471 | +608.6% | 0.00% | +300.0% |
| Q4 2016 | $239,000 | +8.1% | 7,405 | +196.6% | 0.00% | – |
| Q1 2015 | $221,000 | -2.2% | 2,497 | -2.2% | 0.00% | – |
| Q4 2014 | $226,000 | – | 2,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
| Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
| NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
| Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
| Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
| GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
| Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
| Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
| Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
| Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |